Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.62 USD | +1.69% | -2.16% | -32.34% |
09/04 | Harvard Bioscience Reducing Headcount | MT |
09/04 | Harvard Bioscience, Inc. Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth | CI |
Evolution of the average Target Price on Harvard Bioscience, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Harvard Bioscience, Inc.
Benchmark Company | |
KeyBanc Capital Markets |
EPS Revisions
- Stock Market
- Equities
- HBIO Stock
- Consensus Harvard Bioscience, Inc.